Cargando…
A rare pituitary tumor associated with hyperthyroidism and acromegaly
BACKGROUND: Mixed pituitary TSH/GH adenomas are rare adenomas associated with acromegaly and/or thyrotoxicosis, with or without varying degrees of goiter. In this report, we show a case of pituitary adenoma producing both GH and TSH simultaneously. CASE PRESENTATION: A 27-year-old man was diagnosed...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816123/ https://www.ncbi.nlm.nih.gov/pubmed/36619586 http://dx.doi.org/10.3389/fendo.2022.1072647 |
_version_ | 1784864460370870272 |
---|---|
author | Li, Li Meng, Liheng Liu, Yuping Tamrakar, Rashi Yang, Xi Liang, Xinghuang Zhou, Jia Xian, Jing Huang, Zhenxing Qin, Yingfen |
author_facet | Li, Li Meng, Liheng Liu, Yuping Tamrakar, Rashi Yang, Xi Liang, Xinghuang Zhou, Jia Xian, Jing Huang, Zhenxing Qin, Yingfen |
author_sort | Li, Li |
collection | PubMed |
description | BACKGROUND: Mixed pituitary TSH/GH adenomas are rare adenomas associated with acromegaly and/or thyrotoxicosis, with or without varying degrees of goiter. In this report, we show a case of pituitary adenoma producing both GH and TSH simultaneously. CASE PRESENTATION: A 27-year-old man was diagnosed with pituitary adenoma based on various symptoms and clinical findings. For further examination and treatment, he was hospitalized in our institution. It was likely that this subject had pituitary adenoma producing both GH and TSH. In brain magnetic resonance imaging, there was a giant tumor in the sellar region. After the diagnosis of mixed pituitary TSH/GH adenoma, he was treated with octreotide, then underwent tumor resection, and then received hydrocortisone acetate and levothyroxine sodium. After then, GH and IGF-1 levels were suppressed and thyroid function was normalized. Postoperative immunohistochemistry reports showed GH (+) but TSH (-), which may be insensitive to the antibody used to detect TSH or combined with other factors. CONCLUSIONS: The diagnosis of mixed pituitary TSH/GH adenoma must be combined with clinical manifestations, immunohistochemical staining and relevant hormone levels, and genetic testing if necessary for comprehensive judgment. For patients with large adenomas, it is recommended to use somatostatin analogs to restore TH levels and control the excessive secretion of GH levels before surgery. |
format | Online Article Text |
id | pubmed-9816123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98161232023-01-07 A rare pituitary tumor associated with hyperthyroidism and acromegaly Li, Li Meng, Liheng Liu, Yuping Tamrakar, Rashi Yang, Xi Liang, Xinghuang Zhou, Jia Xian, Jing Huang, Zhenxing Qin, Yingfen Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Mixed pituitary TSH/GH adenomas are rare adenomas associated with acromegaly and/or thyrotoxicosis, with or without varying degrees of goiter. In this report, we show a case of pituitary adenoma producing both GH and TSH simultaneously. CASE PRESENTATION: A 27-year-old man was diagnosed with pituitary adenoma based on various symptoms and clinical findings. For further examination and treatment, he was hospitalized in our institution. It was likely that this subject had pituitary adenoma producing both GH and TSH. In brain magnetic resonance imaging, there was a giant tumor in the sellar region. After the diagnosis of mixed pituitary TSH/GH adenoma, he was treated with octreotide, then underwent tumor resection, and then received hydrocortisone acetate and levothyroxine sodium. After then, GH and IGF-1 levels were suppressed and thyroid function was normalized. Postoperative immunohistochemistry reports showed GH (+) but TSH (-), which may be insensitive to the antibody used to detect TSH or combined with other factors. CONCLUSIONS: The diagnosis of mixed pituitary TSH/GH adenoma must be combined with clinical manifestations, immunohistochemical staining and relevant hormone levels, and genetic testing if necessary for comprehensive judgment. For patients with large adenomas, it is recommended to use somatostatin analogs to restore TH levels and control the excessive secretion of GH levels before surgery. Frontiers Media S.A. 2022-12-23 /pmc/articles/PMC9816123/ /pubmed/36619586 http://dx.doi.org/10.3389/fendo.2022.1072647 Text en Copyright © 2022 Li, Meng, Liu, Tamrakar, Yang, Liang, Zhou, Xian, Huang and Qin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Li, Li Meng, Liheng Liu, Yuping Tamrakar, Rashi Yang, Xi Liang, Xinghuang Zhou, Jia Xian, Jing Huang, Zhenxing Qin, Yingfen A rare pituitary tumor associated with hyperthyroidism and acromegaly |
title | A rare pituitary tumor associated with hyperthyroidism and acromegaly |
title_full | A rare pituitary tumor associated with hyperthyroidism and acromegaly |
title_fullStr | A rare pituitary tumor associated with hyperthyroidism and acromegaly |
title_full_unstemmed | A rare pituitary tumor associated with hyperthyroidism and acromegaly |
title_short | A rare pituitary tumor associated with hyperthyroidism and acromegaly |
title_sort | rare pituitary tumor associated with hyperthyroidism and acromegaly |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816123/ https://www.ncbi.nlm.nih.gov/pubmed/36619586 http://dx.doi.org/10.3389/fendo.2022.1072647 |
work_keys_str_mv | AT lili ararepituitarytumorassociatedwithhyperthyroidismandacromegaly AT mengliheng ararepituitarytumorassociatedwithhyperthyroidismandacromegaly AT liuyuping ararepituitarytumorassociatedwithhyperthyroidismandacromegaly AT tamrakarrashi ararepituitarytumorassociatedwithhyperthyroidismandacromegaly AT yangxi ararepituitarytumorassociatedwithhyperthyroidismandacromegaly AT liangxinghuang ararepituitarytumorassociatedwithhyperthyroidismandacromegaly AT zhoujia ararepituitarytumorassociatedwithhyperthyroidismandacromegaly AT xianjing ararepituitarytumorassociatedwithhyperthyroidismandacromegaly AT huangzhenxing ararepituitarytumorassociatedwithhyperthyroidismandacromegaly AT qinyingfen ararepituitarytumorassociatedwithhyperthyroidismandacromegaly AT lili rarepituitarytumorassociatedwithhyperthyroidismandacromegaly AT mengliheng rarepituitarytumorassociatedwithhyperthyroidismandacromegaly AT liuyuping rarepituitarytumorassociatedwithhyperthyroidismandacromegaly AT tamrakarrashi rarepituitarytumorassociatedwithhyperthyroidismandacromegaly AT yangxi rarepituitarytumorassociatedwithhyperthyroidismandacromegaly AT liangxinghuang rarepituitarytumorassociatedwithhyperthyroidismandacromegaly AT zhoujia rarepituitarytumorassociatedwithhyperthyroidismandacromegaly AT xianjing rarepituitarytumorassociatedwithhyperthyroidismandacromegaly AT huangzhenxing rarepituitarytumorassociatedwithhyperthyroidismandacromegaly AT qinyingfen rarepituitarytumorassociatedwithhyperthyroidismandacromegaly |